ALZCHEM GROUP AG (ACT.DE) Stock Price, Quote, News and Overview
FRA:ACT - Deutsche Boerse Ag - DE000A2YNT30 - Common Stock - Currency: EUR
ACT.DE Quote, Performance and Key Statistics
FRA:ACT (3/7/2025, 7:00:00 PM)
87.2
+1.8 (+2.11%)
The current stock price of ACT.DE is 87.2 EUR. In the past month the price increased by 36.68%. In the past year, price increased by 193.6%.
ACT.DE Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 6D81.DE | DUPONT DE NEMOURS INC | 19.09 | 29.92B | ||
| DSFIR.AS | DSM-FIRMENICH AG | 10.51 | 25.51B | ||
| BRG.OL | BORREGAARD ASA | 21.84 | 18.00B | ||
| ELK.OL | ELKEM ASA | 29.74 | 14.84B | ||
| SY1.DE | SYMRISE AG | 34.09 | 13.39B | ||
| 1COV.DE | COVESTRO AG | N/A | 11.08B | ||
| AKZA.AS | AKZO NOBEL N.V. | 15.78 | 10.49B | ||
| EVK.DE | EVONIK INDUSTRIES AG | 27.39 | 10.08B | ||
| AMC.DE | ALBEMARLE CORP | N/A | 8.33B | ||
| SYENS.BR | SYENSQO SA | N/A | 7.47B | ||
| AKE.PA | ARKEMA | 10.06 | 6.30B | ||
| WCH.DE | WACKER CHEMIE AG | 30.92 | 4.02B |
Related stock screener links
About ACT.DE
Company Profile
Alzchem Group AG engages in the development, production, and marketing of chemical products. The company is headquartered in Trostberg, Bayern and currently employs 1,689 full-time employees. The Group's operating business is divided into three segments: Specialty Chemicals, Basics & Intermediates and Other & Holding. Its products can be applied in areas, such as nutrition, renewable energy, fine chemicals, agriculture and metallurgy. The firm produces dietary supplements; epoxy resin hardeners for use in adhesives, powder coatings, printed circuit boards and composites; silicon nitride for advanced ceramics and solar wafers; technical gases; specialty fertilizer, germicide for use in pig pens, plant growth regulators and plant protection additives, among others. The company also provides related services. The firm operates production sites in Germany and Sweden, a sales subsidiary in the United States and a Chinese subsidiary for the purchase of raw materials and distribution in Asia.
Company Info
ALZCHEM GROUP AG
Chemiepark Trostberg, Dr. Albert-Frank-Str. 32
Trostberg BAYERN DE
Employees: 1607
Company Website: https://www.alzchem.com/de
Investor Relations: http://www.alzchem.com/en/investor-relations
Phone: 498621860
ALZCHEM GROUP AG / ACT.DE FAQ
What is the stock price of ALZCHEM GROUP AG today?
The current stock price of ACT.DE is 87.2 EUR. The price increased by 2.11% in the last trading session.
What is the ticker symbol for ALZCHEM GROUP AG stock?
The exchange symbol of ALZCHEM GROUP AG is ACT and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is ACT.DE stock listed?
ACT.DE stock is listed on the Deutsche Boerse Ag exchange.
What is the price forecast or stock price prediction for ALZCHEM GROUP AG stock?
10 analysts have analysed ACT.DE and the average price target is 77.21 EUR. This implies a price decrease of -11.45% is expected in the next year compared to the current price of 87.2. Check the ALZCHEM GROUP AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ALZCHEM GROUP AG worth?
ALZCHEM GROUP AG (ACT.DE) has a market capitalization of 887.70M EUR. This makes ACT.DE a Small Cap stock.
How many employees does ALZCHEM GROUP AG have?
ALZCHEM GROUP AG (ACT.DE) currently has 1607 employees.
What are the support and resistance levels for ALZCHEM GROUP AG (ACT.DE) stock?
ALZCHEM GROUP AG (ACT.DE) has a support level at 67.58. Check the full technical report for a detailed analysis of ACT.DE support and resistance levels.
Is ALZCHEM GROUP AG (ACT.DE) expected to grow?
The Revenue of ALZCHEM GROUP AG (ACT.DE) is expected to grow by 4.75% in the next year. Check the estimates tab for more information on the ACT.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ALZCHEM GROUP AG (ACT.DE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ACT.DE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ACT.DE, evaluating the profitability, health, valuation and growth aspects
- ALZCHEM GROUP AG (ACT.DE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ALZCHEM GROUP AG (ACT.DE) Sales and EPS estimates to see what analysts future expectations are.
- ALZCHEM GROUP AG (ACT.DE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ALZCHEM GROUP AG (ACT.DE) Insider and Institutional Ownership to learn about the owners and their transactions.
- ALZCHEM GROUP AG (ACT.DE) Stock Chart to make your own analysis
- ALZCHEM GROUP AG (ACT.DE) Latest news and press-releases to stay up to date.
Does ALZCHEM GROUP AG (ACT.DE) stock pay dividends?
ALZCHEM GROUP AG (ACT.DE) has a dividend yield of 2.11%. The yearly dividend amount is currently 1.2. Check the full fundamental report for a detailed analysis of ACT.DE dividend history, reliability and sustainability.
When does ALZCHEM GROUP AG (ACT.DE) report earnings?
ALZCHEM GROUP AG (ACT.DE) will report earnings on 2025-04-30.
What is the Price/Earnings (PE) ratio of ALZCHEM GROUP AG (ACT.DE)?
The PE ratio for ALZCHEM GROUP AG (ACT.DE) is 16.39. This is based on the reported non-GAAP earnings per share of 5.32 and the current share price of 87.2 EUR. Check the full fundamental report for a full analysis of the valuation metrics for ACT.DE.
ACT.DE Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to ACT.DE. When comparing the yearly performance of all stocks, ACT.DE is one of the better performing stocks in the market, outperforming 99.59% of all stocks.
ACT.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to ACT.DE. Both the health and profitability get an excellent rating, making ACT.DE a very profitable company, without any liquidiy or solvency issues.
ACT.DE Financial Highlights
Over the last trailing twelve months ACT.DE reported a non-GAAP Earnings per Share(EPS) of 5.32. The EPS increased by 56.41% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.76% | ||
| ROA | 11.18% | ||
| ROE | 26.31% | ||
| Debt/Equity | 0.21 |
ACT.DE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 86% to ACT.DE. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of 7.77% and a revenue growth 4.75% for ACT.DE